These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 28051228

  • 61. Behavioural abnormalities in children with nephrotic syndrome--an underappreciated complication of a standard treatment?
    Neuhaus TJ, Langlois V, Licht C.
    Nephrol Dial Transplant; 2010 Aug; 25(8):2397-9. PubMed ID: 20573807
    [Abstract] [Full Text] [Related]

  • 62. [The effect of treatment methods on frequency of relapse in nephrotic syndrome in children].
    Goszczyk A, Jung A, Bochniewska V, Straz-Zebrowska E.
    Pol Merkur Lekarski; 2000 Sep; 9 Suppl 1():25-6. PubMed ID: 11081338
    [Abstract] [Full Text] [Related]

  • 63. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y.
    Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
    [Abstract] [Full Text] [Related]

  • 64. [Cyclophosphamide in idiopathic nephrotic syndrome: Outcome and outlook].
    Berkane M, Adarmouch L, Amine M, Bourrahouat A, Ait Sab I, Sbihi M.
    Nephrol Ther; 2018 Apr; 14(2):85-90. PubMed ID: 29631702
    [Abstract] [Full Text] [Related]

  • 65. Initial remission-inducing effect of very low-dose cyclosporin monotherapy for minimal-change nephrotic syndrome in Japanese adults.
    Matsumoto H, Nakao T, Okada T, Nagaoka Y, Shino T, Yoshino M, Hidaka H.
    Clin Nephrol; 2001 Feb; 55(2):143-8. PubMed ID: 11269678
    [Abstract] [Full Text] [Related]

  • 66. Initial steroid regimen in idiopathic nephrotic syndrome can be shortened based on duration to first remission.
    Baek HS, Park KS, Kang HG, Ko CW, Cho MH.
    Korean J Pediatr; 2015 Jun; 58(6):206-10. PubMed ID: 26213548
    [Abstract] [Full Text] [Related]

  • 67. Relapse in steroid-sensitive nephrotic syndrome: are extracellular vesicles the missing link?
    Myette RL, Burger D.
    Am J Physiol Renal Physiol; 2021 Nov 01; 321(5):F656-F658. PubMed ID: 34569254
    [No Abstract] [Full Text] [Related]

  • 68. Treatment-Associated Side Effects in Patients with Steroid-Dependent Nephrotic Syndrome.
    Croitoru A, Balgradean M.
    Maedica (Bucur); 2022 Jun 01; 17(2):285-290. PubMed ID: 36032609
    [Abstract] [Full Text] [Related]

  • 69. Management of steroid-responsive nephrotic syndrome.
    Niaudet P, Broyer M.
    Pediatr Nephrol; 2000 Aug 01; 14(8-9):770-1. PubMed ID: 10955924
    [No Abstract] [Full Text] [Related]

  • 70. Lovastatin and nephrotic syndrome.
    Ahmad S.
    South Med J; 1991 Apr 01; 84(4):540-1. PubMed ID: 2014453
    [No Abstract] [Full Text] [Related]

  • 71. Risk Factors for Poor Prognosis of Severe Infection in Children With Idiopathic Nephrotic Syndrome: A Double-Center, Retrospective Study.
    Zhang H, Qiu S, Zhong C, Shi L, Li J, Zhang T, Zhu X, Wang M.
    Front Pediatr; 2021 Apr 01; 9():656215. PubMed ID: 34336733
    [Abstract] [Full Text] [Related]

  • 72. Risk factors for relapse in childhood nephrotic syndrome.
    Takeda A, Matsutani H, Niimura F, Ohgushi H.
    Pediatr Nephrol; 1996 Dec 01; 10(6):740-1. PubMed ID: 8971894
    [Abstract] [Full Text] [Related]

  • 73. Recent advances in understanding and treating nephrotic syndrome.
    Bierzynska A, Saleem M.
    F1000Res; 2017 Dec 01; 6():121. PubMed ID: 28232870
    [Abstract] [Full Text] [Related]

  • 74. Renal Tubular Complement 3 Deposition in Children with Primary Nephrotic Syndrome.
    Wang F, Li X, Zhu X, Chen Q, Jiang L, Zhu Z.
    Biomed Res Int; 2018 Dec 01; 2018():4386438. PubMed ID: 30003098
    [Abstract] [Full Text] [Related]

  • 75. Nephrotic syndrome in children: risk factors for steroid dependence.
    Jellouli M, Brika M, Abidi K, Ferjani M, Naija O, Hammi Y, Gargah T.
    Tunis Med; 2016 Jul 01; 94(7):401-405. PubMed ID: 28051228
    [Abstract] [Full Text] [Related]

  • 76. Risk factors for steroid dependency in children with idiopathic nephrotic syndrome.
    Yap HK, Han EJ, Heng CK, Gong WK.
    Pediatr Nephrol; 2001 Dec 01; 16(12):1049-52. PubMed ID: 11793098
    [Abstract] [Full Text] [Related]

  • 77. Prediction of high-degree steroid dependency in pediatric idiopathic nephrotic syndrome.
    Letavernier B, Letavernier E, Leroy S, Baudet-Bonneville V, Bensman A, Ulinski T.
    Pediatr Nephrol; 2008 Dec 01; 23(12):2221-6. PubMed ID: 18618150
    [Abstract] [Full Text] [Related]

  • 78. Prediction of steroid-sparing agent use in childhood idiopathic nephrotic syndrome.
    Harambat J, Godron A, Ernould S, Rigothier C, Llanas B, Leroy S.
    Pediatr Nephrol; 2013 Apr 01; 28(4):631-8. PubMed ID: 23179197
    [Abstract] [Full Text] [Related]

  • 79. Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.
    Ravani P, Bonanni A, Rossi R, Caridi G, Ghiggeri GM.
    Clin J Am Soc Nephrol; 2016 Apr 07; 11(4):710-20. PubMed ID: 26585985
    [Abstract] [Full Text] [Related]

  • 80. Nephrotic syndrome in children: risk factors for steroid dependence.
    Jellouli M, Brika M, Abidi K, Ferjani M, Naija O, Hammi Y, Gargah T.
    Tunis Med; 2016 Jul 07; 94(7):401-405. PubMed ID: 28051228
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.